94261 ā
Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
Sub-classes:METHOD FOR PREPARING META-(CHIRAL ALLYL)-SUBSTITUTED PYRIDINE COMPOUND
#2Organic Electroluminescent Device
#3INHIBITORS OF THE INTERACTION BETWEEN TRIP8B AND HCN CHANNELS AND USES THEREOF FOR TREATING NEUROLOGICAL DISEASES AND DISORDERS
#4METTL3 MODULATORS
#5Small molecule inhibition of sulfotransferase SULT1A3
#6Heterocyclic compound and organic light emitting device comprising the same
#7Quinolines, polyquinolines, molecular segments of fullerenes and graphene nanoribbons, and graphene nanoribbons and methods of their synthesis
#8Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof
#9Organic electroluminescence device
#10Compositions and methods for treating tuberculosis
#11Heterocyclic compound and organic light emitting device using same
#12Stabilization of active metal catalysts at metal-organic framework nodes for highly efficient organic transformations
#13Halogenated quinoline derivatives as antimicrobial agents
#14Quinoline derivatives and preparation thereof
#15Compositions and methods for treating tuberculosis
#16Fluorescence-based chemical detection of amine-based substances
#17Compound and organic electronic device comprising same
#18Magnetically separable iron-based heterogeneous catalysts for dehydrogenation of alcohols and amines
#19Quinolines and process for the preparation thereof
#20Quinolines, polyquinolines, molecular segments of fullerenes and graphene nanoribbons, and graphene nanoribbons and methods of their synthesis
#21SUBSTITUTED 1,2-DIHYDROQUINOLINES WITH LOW CONTAMINANT LEVELS AND PROCESSES FOR PREPARING
#22Immunoregulatory agents
#23Acid diffusion control agent, radiation-sensitive resin composition, resist pattern-forming method, compound, and production method
#24Process for fluorinating compounds
#25Method for manufacturing optically active compound
#26Immunoregulatory agents
#273-(4-(benzyloxy)phenyl)hex-4-ynoic acid derivative, method of preparing same and pharmaceutical composition for preventing and treating metabolic disease including same as effective ingredient
#28ANTHRACENE COMPOUND, METHOD FOR PREPARING THE SAME, USE THEREOF AND ORGANIC LIGHT EMITTING DEVICE
#29Pyrene compound and organic light emitting diode device including the same
#30Method for producing purified amine compound
#31Organic electroluminescence device
#32Quinoline derivatives useful as CB-1 inverse agonists
#33Acid diffusion control agent, radiation-sensitive resin composition, resist pattern-forming method, compound, and production method
#34Process for the preparation of a quinoline carboxylic acid
#35Organic compound and organic light emitting diode device including the same
#36Method for producing optically active tetrahydroquinolines
#37Amino azaheterocyclic carboxamides
#38Condensed-cyclic compound and organic light-emitting diode including the condensed-cyclic compound
#39Pyrene compound and organic light emitting diode device including the same
#40Androgen receptor modulator compounds and methods
#41Organic electroluminescent element and compound
#42Polymorphs of pitavastatin calcium
#43Naphth-2-ylacetic acid derivatives to treat AIDS
#44Organic compounds
#45Cure accelerators for anaerobic curable compositions
#46Organic electroluminescence device
#47Compositions and methods for the treatment of disease associated with TRP-P8 expression
#48Organic compound and organic light-emitting device
#49Amino azaheterocyclic carboxamides
#50Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and SIRT1, and methods of treating disorders
#51DERIVATIVES OF HETEROARYL-ALKYLCARBAMATES, METHODS FOR THEIR PREPARATION AND USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS
#52Method for producing unsaturated organic compound
#53Compounds having electroluminescent or electron transport properties
#54Fused heterocyclic compounds as inhibitors of potassium channel function
#55Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
#56AMIDE AND UREA DERIVATIVES FOR THE TREATMENT OF METABOLIC DISEASES
#57DERIVATIVES OF HETEROARYL-ALKYLCARBAMATES, METHODS FOR THEIR PREPARATION AND USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS
#58ANTIBACTERIAL QUINOLINE DERIVATIVES
#59Substituted arylalkanoic acid derivatives and use thereof
#60Benzofluoranthene compound and organic light-emitting device using the compound
#61Novel organic electroluminescent compounds and organic electroluminescent device using the same
#62Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
#63S1Preceptor antagonist
#64Metal complexes
#65Copper-catalyzed CāH bond arylation
#66Substituted arylalkanoic acid derivatives and use thereof
#67Substituted biaryl compounds as factor XIa inhibitors
#68Utilities of olefin derivatives
#69Compound and organic light emitting device
#70New utilities of tricyclic compounds
#713-(dihydro(tetrahydro)isoquinolin-1-yl)quinoline compound
#72Triarylamine derivative
#73MULTIPLY-SUBSTITUTED TETRAHYDRONAPHTHALENE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE AS ANTI-INFLAMMATORY AGENTS
#74Anthracene derivative and organic electroluminescent element using the same
#75Organoelectroluminescent compound and organoelectroluminescent device employing the same
#76Method for the synthesis of 3-substituted indolizine and benzoindolizine compounds
#771,2,3,4-tetrahydro-quinoline derivatives as CETP inhibitors
#78Androgen receptor modulator compounds and methods
#79Substituted arylalkanoic acid derivatives and use thereof
#80Process for the synthesis of quinoline derivatives
#81Chiral ligands and their transition metal complexes
#82Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors
#83Hydroxysteroid dehydrogenase inhibitors
#84Beta-sulfonamide hydroxamic acid inhibitors of tace/matrix metalloproteinase
#85Method for the synthesis of 3-substituted indolizine and benzoindolizine compounds
#86Substituted biaryl compounds as factor XIa inhibitors
#87Synthesis and uses of synephrine derivatives
#88Quinazolinyl compounds as inhibitors of potassium channel function
#89Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
#908-(biaryl)quinoline PDE4 inhibitors
#91Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
#92Metabotropic glutamate receptor antagonists
#93Phenyl-and pyridyl-diazaheterocycles having a tnf-modulating activity
#94Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
#95Substituted quinolines for the treatment of protozoa and retrovirus co-infections
#96Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made such compounds
#97Compositions and methods for the treatment of disease associated with Trp-p8 expression
#98Aza-and polyaza-naphthalenly ketones useful as hiv integrase inhibitors